IMITREX- sumatriptan succinate tablet, film coated 
GlaxoSmithKline Inc

----------

Principal Display Panel

NDC 0173-0735-00

IMITREX®

(SUMATRIPTAN SUCCINATE)

TABLETS

25 mg

Rx only

Each tablet contains sumatriptan succinate equivalent to 25 mg of sumatriptan.

9 Tablets

 
10000000146158 Rev. 6/17
Imitex 25mg 9 count carton

Principal Display Panel

NDC 0173-0736-01

IMITREX®

(SUMATRIPTAN SUCCINATE)

TABLETS

50 mg

Rx only

Each tablet contains sumatriptan succinate equivalent to 50 mg of sumatriptan.

9 Tablets

 
10000000146157 Rev. 6/17
Imitex 50mg 9 count carton

Principal Display Panel

NDC 0173-0737-01

IMITREX®

(SUMATRIPTAN SUCCINATE)

TABLETS

100 mg

Rx only

Each tablet contains sumatriptan succinate equivalent to 100 mg of sumatriptan.

9 Tablets

 
10000000146401 Rev. 6/17
Imitex 100mg 9 count carton
IMITREX 
sumatriptan succinate tablet, film coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:53873-028
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SUMATRIPTAN SUCCINATE (UNII: J8BDZ68989) (SUMATRIPTAN - UNII:8R78F6L9VO) SUMATRIPTAN25 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
Product Characteristics
ColorWHITEScoreno score
ShapeTRIANGLE (triangular-shaped) Size9mm
FlavorImprint Code I;25
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53873-028-009 in 1 BLISTER PACK; Type 0: Not a Combination Product12/17/2003
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02013212/17/2003
IMITREX 
sumatriptan succinate tablet, film coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:53873-029
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SUMATRIPTAN SUCCINATE (UNII: J8BDZ68989) (SUMATRIPTAN - UNII:8R78F6L9VO) SUMATRIPTAN50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
Product Characteristics
ColorWHITEScoreno score
ShapeTRIANGLE (triangular-shaped) Size11mm
FlavorImprint Code IMITREX;50
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53873-029-009 in 1 BLISTER PACK; Type 0: Not a Combination Product12/17/2003
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02013212/17/2003
IMITREX 
sumatriptan succinate tablet, film coated
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:53873-030
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SUMATRIPTAN SUCCINATE (UNII: J8BDZ68989) (SUMATRIPTAN - UNII:8R78F6L9VO) SUMATRIPTAN100 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIACETIN (UNII: XHX3C3X673)  
Product Characteristics
ColorPINKScoreno score
ShapeTRIANGLE (triangular-shaped) Size11mm
FlavorImprint Code IMITREX;100
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53873-030-009 in 1 BLISTER PACK; Type 0: Not a Combination Product12/19/2003
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Approved Drug Product Manufactured Under ContractNDA02013212/19/2003
Labeler - GlaxoSmithKline Inc (205556368)

Revised: 12/2017
 
GlaxoSmithKline Inc